The Lysine Methylase SMYD3 Modulates Mesendodermal Commitment during Development

SMYD3 (SET and MYND domain containing protein 3) is a methylase over-expressed in cancer cells and involved in oncogenesis. While several studies uncovered key functions for SMYD3 in cancer models, the SMYD3 role in physiological conditions has not been fully elucidated yet. Here, we dissect the rol...

Full description

Bibliographic Details
Published in:	Cells
Main Authors:	Raffaella Fittipaldi, Pamela Floris, Valentina Proserpio, Franco Cotelli, Monica Beltrame, Giuseppina Caretti
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Subjects:	embryonic stem cells SMYD3 zebrafish development
Online Access:	https://www.mdpi.com/2073-4409/10/5/1233

Similar Items

Targeting Epigenetic Changes Mediated by Members of the SMYD Family of Lysine Methyltransferases
by: Alyssa Padilla, et al.
Published: (2023-02-01)

The Lysine Methyltransferase SMYD2 Is Required for Definite Hematopoietic Stem Cell Production in the Mouse Embryo
by: Melissa A. Edwards, et al.
Published: (2020-07-01)

SMYD3 Modulates the HGF/MET Signaling Pathway in Gastric Cancer
by: Katia De Marco, et al.
Published: (2023-10-01)

The lysine methyltransferase SMYD2 facilitates neointimal hyperplasia by regulating the HDAC3–SRF axis
by: Xiaoxuan Zhong, et al.
Published: (2024-02-01)

SMYD4 promotes MYH9 ubiquitination through lysine monomethylation modification to inhibit breast cancer progression
by: Jin-Shuo Yang, et al.
Published: (2025-02-01)

SMYD2 promotes cervical cancer growth by stimulating cell proliferation
by: Jun-Jie Sun, et al.
Published: (2019-09-01)

Overexpression of SMYD3 Promotes Autosomal Dominant Polycystic Kidney Disease by Mediating Cell Proliferation and Genome Instability
by: Ewud Agborbesong, et al.
Published: (2024-03-01)

Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via H3K4me3-mediated HMGA2 transcription
by: Zongcheng Yang, et al.
Published: (2023-05-01)

Mouse myofibers lacking the SMYD1 methyltransferase are susceptible to atrophy, internalization of nuclei and myofibrillar disarray
by: M. David Stewart, et al.
Published: (2016-03-01)

Identification of SMYD2 as a candidate diagnostic and prognostic biomarker for gastric cancer
by: Sichao Wang, et al.
Published: (2025-07-01)

The chromatin remodeling factors EP300 and TRRAP are novel SMYD3 interactors involved in the emerging ‘nonmutational epigenetic reprogramming’ cancer hallmark
by: Candida Fasano, et al.
Published: (2023-01-01)

SMYD3 confers cisplatin chemoresistance of NSCLC cells in an ANKHD1-dependent manner
by: Hong-Wei Lv, et al.
Published: (2021-06-01)

SMYD2 Promotes Calcium Oxalate-Induced Glycolysis in Renal Tubular Epithelial Cells via PTEN Methylation
by: Shengyu Pan, et al.
Published: (2024-10-01)

SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis
by: Kangdi Xu, et al.
Published: (2022-12-01)

SMYD5-BRD4 Interaction Drives Hepatocellular Carcinoma Progression: A Combined in Silico and Experimental Analysis
by: Mingye Hu, et al.
Published: (2025-07-01)

SMYD2 inhibitors have no effect in improving non-alcoholic steatohepatitis in mice
by: Lanzexin Yang, et al.
Published: (2025-06-01)

The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance
by: Paola Sanese, et al.
Published: (2024-05-01)

SMYD3 Modulates AMPK-mTOR Signaling Balance in Cancer Cell Response to DNA Damage
by: Martina Lepore Signorile, et al.
Published: (2023-11-01)

Host factor SMYD3 is recruited by Ebola virus nucleoprotein to facilitate viral mRNA transcription
by: Jingliang Chen, et al.
Published: (2019-01-01)

Is MYND Domain-Mediated Assembly of SMYD3 Complexes Involved in Calcium Dependent Signaling?
by: Yingxue Zhang, et al.
Published: (2019-11-01)

Relationships between progrosis, immune infiltration and expression of SMYD3 in pan-cancer
by: CHEN Haoran, SI Tian, JIANG Yishen, WANG Dianheng, ZHOU Yabo, LYU Jiadi
Published: (2023-01-01)

The Methyltransferase Smyd1 Mediates LPS-Triggered Up-Regulation of IL-6 in Endothelial Cells
by: Ahmed Shamloul, et al.
Published: (2021-12-01)

Pharmacological inhibition of SMYD2 protects against cisplatin-induced acute kidney injury in mice
by: Binbin Cui, et al.
Published: (2022-08-01)

A Positive Feedback Loop of lncRNA HOXD-AS2 and SMYD3 Facilitates Hepatocellular Carcinoma Progression via the MEK/ERK Pathway
by: Sun J, et al.
Published: (2023-07-01)

Effect of SMYD3 on Biological Behavior and H3K4 Methylation in Bladder Cancer [Retraction]
by: Wu X, et al.
Published: (2023-07-01)

Dissecting the Role of SMYD2 and Its Inhibitor (LLY-507) in the Treatment of Chemically Induced Non-Small Cell Lung Cancer (NSCLC) by Using Fe<sub>3</sub>O<sub>4</sub> Nanoparticles Drug Delivery System
by: Aasma Munawwar, et al.
Published: (2023-07-01)

SMYD3 associates with the NuRD (MTA1/2) complex to regulate transcription and promote proliferation and invasiveness in hepatocellular carcinoma cells
by: Yang Yang, et al.
Published: (2022-12-01)

Unveiling Smyd-2’s Role in Cytoplasmic Nrf-2 Sequestration and Ferroptosis Induction in Hippocampal Neurons After Cerebral Ischemia/Reperfusion
by: Daohang Liu, et al.
Published: (2024-11-01)

Novel regulation mechanism of histone methyltransferase SMYD5 in rheumatoid arthritis
by: Chenxi Xiao, et al.
Published: (2025-03-01)

Endurance training and MitoQ supplementation increase PERM1 and SMYD1 gene expression and improve hemodynamic function in cardiac muscle of male Wistar rats
by: mahboube salajeghe tezergi, et al.
Published: (2024-12-01)

CircSMYD4 regulates proliferation, migration and apoptosis of hepatocellular carcinoma cells by sponging miR-584-5p
by: Yanhe Zhang, et al.
Published: (2020-11-01)

SMYD2 epigenetically activates BMP4/SMAD1/5/8/ID3 axis to enhance cancer stem cell properties and drive sorafenib resistance in hepatocellular carcinoma
by: Shanshan Wang, et al.
Published: (2025-09-01)

Unique SMYD5 Structure Revealed by AlphaFold Correlates with Its Functional Divergence
by: Yingxue Zhang, et al.
Published: (2022-06-01)

Design, synthesis, and biological evaluation of SMYD3 inhibitors possessing N-thiazole benzenesulfonamide moiety as potential anti-cancer agents
by: Suaad Abdallah Audat, et al.
Published: (2022-05-01)

SMYD3 Promotes Immune Evasion in Clear Cell Renal Cell Carcinoma via SREBP1‐Mediated Transactivation of CD47
by: Zhengfang Liu, et al.
Published: (2025-09-01)

SMYD2 Inhibition Downregulates TMPRSS2 and Decreases SARS-CoV-2 Infection in Human Intestinal and Airway Epithelial Cells
by: Yu-Qiang Yu, et al.
Published: (2022-04-01)

Functional and Structural Annotation of Uncharacterized Lysine Methyltransferase Proteins in <i>Candida auris</i>
by: Himanshu Kishore Prasad
Published: (2024-04-01)

SMYD1 modulates the proliferation of multipotent cardiac progenitor cells derived from human pluripotent stem cells during myocardial differentiation through GSK3β/β-catenin&ERK signaling
by: Yun Chang, et al.
Published: (2024-10-01)

The SMYD3-dependent H3K4me3 status of IGF2 intensifies local Th2 differentiation in CRSwNP via positive feedback
by: Lei Yu, et al.
Published: (2023-11-01)

Loss of histone methyltransferase Smyd3 triggers WAT browning and adaptive thermogenesis via enhancing PPARγ expression in a H4K20me3-dependent manner
by: Meiling Shu, et al.
Published: (2025-10-01)